MedTrace Logo

Laser Therapy in Managing Vaginal Prolapse

NCT03714607 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2019-09-17

No results posted yet for this study

Summary

Efficacy of laser therapy in postmenopausal women with symptomatic prolapse stage \>1. Assessment tools will include prolapse stage quantification system (POP-Q) and validated condition related questionnaires.

Conditions

  • Cystocele
  • Vaginal Vault Prolapse
  • Rectocele
  • Enterocele

Interventions

DEVICE

Erbium Yttrium Aluminum Garnet (Er:YAG) laser

5 Er:YAG laser therapies vaginally administered at monthly intervals

Sponsors & Collaborators

  • National and Kapodistrian University of Athens

    lead OTHER

Principal Investigators

  • Stavros Athanasiou, Associate Proffesor · National and Kapodistrian University of Athens, Greece

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-30
Primary Completion
2019-12-31
Completion
2020-01-31

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03714607 on ClinicalTrials.gov